[Increase in survival in acute lymphoblastic leukemia subjected to a protocol of polychemotherapy].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality*; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D010166:Palliative Care; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate
Augmentation de l'espoir de vie des leucémies aiguës lymphoblastiques soumises à un protocole de polychimiothérapie.